| Net Cash Provided by (Used in) Operating Activities |
$3,315,172 |
USD |
-51% |
Q2 2025 |
Q1 2026 |
| Net Cash Provided by (Used in) Financing Activities |
$6,496,216 |
USD |
|
Q2 2025 |
Q1 2026 |
| Common Stock, Shares Authorized |
200,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Common Stock, Shares, Issued |
14,385,202 |
shares |
33% |
Q3 2025 |
Q2 2026 |
| Common Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$3,181,044 |
USD |
|
Q2 2025 |
Q1 2026 |
| Deferred Tax Assets, Valuation Allowance |
$14,619,000 |
USD |
22% |
Q1 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$16,349,000 |
USD |
19% |
Q1 2025 |
FY 2025 |
| Operating Lease, Liability |
$83,121 |
USD |
97% |
Q3 2025 |
Q2 2026 |
| Depreciation |
$40,972 |
USD |
26% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid |
$90,455 |
USD |
108% |
Q3 2025 |
Q2 2026 |
| Property, Plant and Equipment, Gross |
$1,724,779 |
USD |
188% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Liability, Current |
$48,710 |
USD |
16% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year Two |
$14,400 |
USD |
|
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, to be Paid, Year One |
$43,200 |
USD |
231% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Weighted Average Discount Rate, Percent |
0.0969 |
pure |
21% |
Q3 2025 |
Q2 2026 |
| Lessee, Operating Lease, Liability, Undiscounted Excess Amount |
$7,334 |
USD |
418% |
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$14,586,000 |
USD |
18% |
Q1 2025 |
FY 2025 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Authorized |
50,000,000 |
shares |
0% |
Q3 2025 |
Q2 2026 |
| Operating Lease, Payments |
$15,423 |
USD |
1.1% |
Q2 2025 |
Q1 2026 |
| Additional Paid in Capital |
$124,534,247 |
USD |
38% |
Q3 2025 |
Q2 2026 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q3 2025 |
Q2 2026 |
| Deferred Tax Assets, Net of Valuation Allowance |
$1,730,000 |
USD |
-0.52% |
Q1 2025 |
FY 2025 |
| Share-based Payment Arrangement, Expense |
$55,268 |
USD |
|
Q3 2025 |
Q2 2026 |
| Preferred Stock, Par or Stated Value Per Share |
0.001 |
USD/shares |
0% |
Q3 2025 |
Q2 2026 |